Open AccessDilated cardiomyopathy and aldosteronoma: a causal link?
Author(s) -
Zhang Jiyu,
Yang Jin,
Li Yueliang
Publication year - 2020
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.12579
Subject(s) - medicine , dilated cardiomyopathy , spironolactone , heart failure , cardiology , cardiomyopathy
The aim of this study is to reveal the causal relationship between dilated cardiomyopathy and aldosteronoma. A 44‐year‐old male dilated cardiomyopathy patient with aldosteronoma, who demonstrated a worse cardiac function after 1 year therapy with optimized dosage of sacubirtil/valsartan, furosemide, metoprolol, and spironolactone. The patient shows a promising prognosis after aldosteronoma removal procedure. Aldosteronoma may cause dilated cardiomyopathy. We assume that the optimal treatment for aldosteronoma‐induced dilated cardiomyopathy is surgical removal combined with drugs.